Diffusion of biopsy confirmed DCIS and malignant lesions with high b values in an innovative 3T MRI

Diffusion of biopsy confirmed DCIS and malignant lesions with high b values in an innovative 3T MRI - Daffodil

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00034291

Enrollment

Registered

2025-03-10

Start date

2024-10-25

Completion date

Unknown

Last updated

2026-02-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50.9

Interventions

Group 1: patients with lesions suspicious for malignancy recieve a breast MRI in a high end scanner with special DWI sequences before a clinically indicated study-independent planned biopsy, data from

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: 1. All adult patients with DCIS/suspicious breast cancer findings who are to receive a biopsy independent of the study 2. Present written consent

Exclusion criteria

Exclusion criteria: Contraindications to MRI/MRI contrast media Pregnancy Biopsy has already been carried out for only one lesion

Design outcomes

Primary

Measure	Time frame
Quality of visualization of breast malignancy and DCIS with DWI in an innovative 3T MRI	—

Secondary

Measure	Time frame
Possibility of differentiation of breast malignancy and DCIS with DWI in an innovative 3T MRI	—

Countries

Germany

Contacts

Public ContactClaudia Neubauer

Universitätsklinikum Freiburg

claudia.neubauer@uniklinik-freiburg.de004976127038060

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 7, 2026